Prokarium is a biotechnology company with a vision to create the best platform for oral delivery of protein vaccines. Our synthetic biology platform Vaxonella makes vaccines more accessible to travellers and people living in rural and resource-poor areas
Prokarium to present at VISION Briefing on ‘Synthetic Biology’
Prokarium’s CSO, Dr Rocky Cranenburgh, will present and partake in a panel debate at the VISION Briefing on ‘Synthetic Biology: An industrial Perspective,’ 30th April 2014, London. For more information visit THIS LINK.